News

AstraZeneca and MSD’s Lynparza (olaparib) has been recommended for marketing authorisation across the European Union for the first-line maintenance treatment with bevacizumab for patients with homologous recombination deficient (HRD)-positive advanced ovarian cancer. This came after the Committee for Medicinal Products...

Bristol Myers Squibb announced that it has successfully completed its transaction to acquire Forbius for their TGF-beta program, including its lead investigational asset AVID200, currently in Phase 1 for oncology and fibrosis. “We are pleased to complete the transaction with...

Russia expects to register another COVID-19 vaccine candidate by mid-October, according to Russian consumer safety watchdog Rospotrebnadzor. Russia expects to register another COVID-19 vaccine candidate by mid-October, according to Russian consumer safety watchdog Rospotrebnadzor. The vaccine candidate “EpiVacCorona”, which completed...

Samsung Biologics and AstraZeneca announced a long-term supply agreement, valued at approximately $330.8 million. Under this agreement, Samsung Biologics will provide large-scale commercial manufacturing for drug substance in its Plant 3 as well as drug product to support AstraZeneca’s...

We all hope that a COVID-19 vaccine is on the horizon - but the global cold chain must be prepared to distribute these vaccines around the world. This is an unprecedented task, with a large number of transfer points across...

Carrying 1 of each 20 air cargo carried around the world, Turkish Cargo increased its global market share to 5.4 percent from 3.9 percent by accomplishing a growth by 67 percent within the first half of 2020 thanks to...

Innovative diagnostics company, Glyconics® has been awarded an internationally recognised quality certification for the design and development of its medical devices product range. Following a review by BSI, one of the world’s leading notified bodies, Glyconics has been awarded ISO...